323 related articles for article (PubMed ID: 8164650)
1. Mutagenic analysis of the roles of SH2 and SH3 domains in regulation of the Abl tyrosine kinase.
Mayer BJ; Baltimore D
Mol Cell Biol; 1994 May; 14(5):2883-94. PubMed ID: 8164650
[TBL] [Abstract][Full Text] [Related]
2. Evidence that SH2 domains promote processive phosphorylation by protein-tyrosine kinases.
Mayer BJ; Hirai H; Sakai R
Curr Biol; 1995 Mar; 5(3):296-305. PubMed ID: 7780740
[TBL] [Abstract][Full Text] [Related]
3. En bloc substitution of the Src homology region 2 domain activates the transforming potential of the c-Abl protein tyrosine kinase.
Muller AJ; Pendergast AM; Parmar K; Havlik MH; Rosenberg N; Witte ON
Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3457-61. PubMed ID: 7682703
[TBL] [Abstract][Full Text] [Related]
4. Identification of a protein that binds to the SH3 region of Abl and is similar to Bcr and GAP-rho.
Cicchetti P; Mayer BJ; Thiel G; Baltimore D
Science; 1992 Aug; 257(5071):803-6. PubMed ID: 1379745
[TBL] [Abstract][Full Text] [Related]
5. Deletion of the SH3 domain of Src interferes with regulation by the phosphorylated carboxyl-terminal tyrosine.
Okada M; Howell BW; Broome MA; Cooper JA
J Biol Chem; 1993 Aug; 268(24):18070-5. PubMed ID: 7688738
[TBL] [Abstract][Full Text] [Related]
6. The Src homology 2 domain of the protein-tyrosine kinase p56lck mediates both intermolecular and intramolecular interactions.
Amrein KE; Panholzer B; Flint NA; Bannwarth W; Burn P
Proc Natl Acad Sci U S A; 1993 Nov; 90(21):10285-9. PubMed ID: 7694287
[TBL] [Abstract][Full Text] [Related]
7. Association of p62, a multifunctional SH2- and SH3-domain-binding protein, with src family tyrosine kinases, Grb2, and phospholipase C gamma-1.
Richard S; Yu D; Blumer KJ; Hausladen D; Olszowy MW; Connelly PA; Shaw AS
Mol Cell Biol; 1995 Jan; 15(1):186-97. PubMed ID: 7799925
[TBL] [Abstract][Full Text] [Related]
8. Direct analysis of the binding of the abl Src homology 2 domain to the activated epidermal growth factor receptor.
Zhu G; Decker SJ; Mayer BJ; Saltiel AR
J Biol Chem; 1993 Jan; 268(3):1775-9. PubMed ID: 7678409
[TBL] [Abstract][Full Text] [Related]
9. Mutational analysis of the regulatory function of the c-Abl Src homology 3 domain.
Brasher BB; Roumiantsev S; Van Etten RA
Oncogene; 2001 Nov; 20(53):7744-52. PubMed ID: 11753652
[TBL] [Abstract][Full Text] [Related]
10. Differential inhibition of signaling pathways by dominant-negative SH2/SH3 adapter proteins.
Tanaka M; Gupta R; Mayer BJ
Mol Cell Biol; 1995 Dec; 15(12):6829-37. PubMed ID: 8524249
[TBL] [Abstract][Full Text] [Related]
11. Physical and functional interactions between SH2 and SH3 domains of the Src family protein tyrosine kinase p59fyn.
Panchamoorthy G; Fukazawa T; Stolz L; Payne G; Reedquist K; Shoelson S; Songyang Z; Cantley L; Walsh C; Band H
Mol Cell Biol; 1994 Sep; 14(9):6372-85. PubMed ID: 7520528
[TBL] [Abstract][Full Text] [Related]
12. The Ras GTPase-activating protein (GAP) is an SH3 domain-binding protein and substrate for the Src-related tyrosine kinase, Hck.
Briggs SD; Bryant SS; Jove R; Sanderson SD; Smithgall TE
J Biol Chem; 1995 Jun; 270(24):14718-24. PubMed ID: 7782336
[TBL] [Abstract][Full Text] [Related]
13. Tyrosine phosphorylation in the SH3 domain disrupts negative regulatory interactions within the c-Abl kinase core.
Chen S; O'Reilly LP; Smithgall TE; Engen JR
J Mol Biol; 2008 Nov; 383(2):414-23. PubMed ID: 18775435
[TBL] [Abstract][Full Text] [Related]
14. Tyrosine-phosphorylated epidermal growth factor receptor and cellular p130 provide high affinity binding substrates to analyze Crk-phosphotyrosine-dependent interactions in vitro.
Birge RB; Fajardo JE; Mayer BJ; Hanafusa H
J Biol Chem; 1992 May; 267(15):10588-95. PubMed ID: 1375224
[TBL] [Abstract][Full Text] [Related]
15. Phosphorylation of the ras GTPase-activating protein (GAP) by the p93c-fes protein-tyrosine kinase in vitro and formation of GAP-fes complexes via an SH2 domain-dependent mechanism.
Hjermstad SJ; Briggs SD; Smithgall TE
Biochemistry; 1993 Oct; 32(39):10519-25. PubMed ID: 7691175
[TBL] [Abstract][Full Text] [Related]
16. Analysis of chimeric Gag-Arg/Abl molecules indicates a distinct negative regulatory role for the Arg C-terminal domain.
Mysliwiec T; Perego R; Kruh GD
Oncogene; 1996 Feb; 12(3):631-40. PubMed ID: 8637720
[TBL] [Abstract][Full Text] [Related]
17. Structure of a regulatory complex involving the Abl SH3 domain, the Crk SH2 domain, and a Crk-derived phosphopeptide.
Donaldson LW; Gish G; Pawson T; Kay LE; Forman-Kay JD
Proc Natl Acad Sci U S A; 2002 Oct; 99(22):14053-8. PubMed ID: 12384576
[TBL] [Abstract][Full Text] [Related]
18. Regulation of Cbl phosphorylation by the Abl tyrosine kinase and the Nck SH2/SH3 adaptor.
Miyoshi-Akiyama T; Aleman LM; Smith JM; Adler CE; Mayer BJ
Oncogene; 2001 Jul; 20(30):4058-69. PubMed ID: 11494134
[TBL] [Abstract][Full Text] [Related]
19. The solution structure of Abl SH3, and its relationship to SH2 in the SH(32) construct.
Gosser YQ; Zheng J; Overduin M; Mayer BJ; Cowburn D
Structure; 1995 Oct; 3(10):1075-86. PubMed ID: 8590002
[TBL] [Abstract][Full Text] [Related]
20. Activation of the focal adhesion kinase signaling pathway by structural alterations in the carboxyl-terminal region of c-Crk II.
Zvara A; Fajardo JE; Escalante M; Cotton G; Muir T; Kirsch KH; Birge RB
Oncogene; 2001 Feb; 20(8):951-61. PubMed ID: 11314030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]